In comparison of insulin users, newly diagnosed T2DM and subjects using NIDA (Fig. 5), blood glucose levels in newly diagnosed T2DM subjects were significantly lower than those in insulin users, although they were not different at the start of SIIT. The gene discussed is INS; the disease is type 2 diabetes mellitus.